BioCentury
ARTICLE | Company News

GSK to end Inex topotecan deal

August 4, 2004 7:00 AM UTC

Inex (TSE:IEX) said GlaxoSmithKline (LSE:GSK; GSK) will terminate their deal to develop liposomal topotecan ( INX-0076) to treat cancer. In November 2001, the companies began preclinical testing of GS...